Published in J R Soc Med on January 01, 1993
Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev (1996) 13.91
Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. Am J Pathol (1997) 2.47
Proficiency testing of clinical microbiology laboratories using modified decontamination procedures for detection of nontuberculous mycobacteria in sputum samples from cystic fibrosis patients. The Nontuberculous Mycobacteria in Cystic Fibrosis Study Group. J Clin Microbiol (1997) 1.44
Distribution of genes encoding putative transmissibility factors among epidemic and nonepidemic strains of Burkholderia cepacia from cystic fibrosis patients in the United Kingdom. J Clin Microbiol (2000) 1.24
Genotypic analysis of respiratory mucous sulfation defects in cystic fibrosis. J Clin Invest (1995) 1.08
Pulmonary retention of free and liposome-encapsulated tobramycin after intratracheal administration in uninfected rats and rats infected with Pseudomonas aeruginosa. Antimicrob Agents Chemother (1994) 0.99
Eradication of mucoid Pseudomonas aeruginosa with fluid liposome-encapsulated tobramycin in an animal model of chronic pulmonary infection. Antimicrob Agents Chemother (1996) 0.99
Heterogeneity of Pseudomonas aeruginosa in Brazilian cystic fibrosis patients. J Clin Microbiol (2001) 0.98
Transmissibility and infection control implications of Burkholderia cepacia in cystic fibrosis. Can J Infect Dis (1998) 0.83
Combination of 16S rRNA variable regions provides a detailed analysis of bacterial community dynamics in the lungs of cystic fibrosis patients. Hum Genomics (2010) 0.79
Pharmacokinetics and efficacies of liposomal and conventional formulations of tobramycin after intratracheal administration in rats with pulmonary Burkholderia cepacia infection. Antimicrob Agents Chemother (2002) 0.75
Pseudomonas cepacia. Arch Dis Child (1994) 0.75
Harnessing Neutrophil Survival Mechanisms during Chronic Infection by Pseudomonas aeruginosa: Novel Therapeutic Targets to Dampen Inflammation in Cystic Fibrosis. Front Cell Infect Microbiol (2017) 0.75
Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr (1984) 9.61
Common themes in microbial pathogenicity. Microbiol Rev (1989) 7.78
Microbiology of airway disease in patients with cystic fibrosis. Clin Microbiol Rev (1991) 7.12
Role of pili in adherence of Pseudomonas aeruginosa to mammalian buccal epithelial cells. Infect Immun (1980) 6.19
Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet (1990) 4.39
Mucoid Pseudomonas aeruginosa and cystic fibrosis: resistance of the mucoid from to carbenicillin, flucloxacillin and tobramycin and the isolation of mucoid variants in vitro. J Antimicrob Chemother (1978) 3.97
Pseudomonas cepacia colonization among patients with cystic fibrosis. A new opportunist. Am Rev Respir Dis (1985) 3.71
Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment. Lancet (1991) 3.26
Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Risk factors and outcomes. Chest (1987) 2.97
Immunohistopathologic localization of Pseudomonas aeruginosa in lungs from patients with cystic fibrosis. Implications for the pathogenesis of progressive lung deterioration. Am Rev Respir Dis (1989) 2.77
Cystic fibrosis in the mouse by targeted insertional mutagenesis. Nature (1992) 2.66
Laboratory proficiency test results on use of selective media for isolating Pseudomonas cepacia from simulated sputum specimens of patients with cystic fibrosis. J Clin Microbiol (1987) 2.31
Adherence of Pseudomonas aeruginosa to human tracheobronchial mucin. Infect Immun (1984) 2.28
Pseudomonas cepacia in inpatients with cystic fibrosis. Lancet (1991) 2.27
Microbiology of lung infection in cystic fibrosis. Br Med Bull (1992) 2.22
Protection against mucoid Pseudomonas aeruginosa in rodent models of endobronchial infections. Science (1990) 2.03
Pseudomonas aeruginosa adhesins for tracheobronchial mucin. Infect Immun (1987) 1.87
Nebulised colomycin for early pseudomonas colonisation in cystic fibrosis. Lancet (1985) 1.86
Binding of Pseudomonas cepacia to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis. J Clin Invest (1992) 1.80
Tracheobronchial mucin receptor for Pseudomonas aeruginosa: predominance of amino sugars in binding sites. Infect Immun (1985) 1.74
Molecular analysis of hemolytic and phospholipase C activities of Pseudomonas cepacia. Infect Immun (1990) 1.73
Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis. Infect Immun (1983) 1.68
The role of immune complexes in the pathogenesis of bacterial infections. Annu Rev Microbiol (1986) 1.67
Cystic fibrosis. 1. Pseudomonas aeruginosa infection in cystic fibrosis and its management. Thorax (1990) 1.67
Quantitation and identification of antibodies to outer-membrane proteins of Pseudomonas aeruginosa in sera of patients with cystic fibrosis. J Infect Dis (1984) 1.62
Pseudomonas aeruginosa recognizes carbohydrate chains containing type 1 (Gal beta 1-3GlcNAc) or type 2 (Gal beta 1-4GlcNAc) disaccharide units. Infect Immun (1991) 1.62
Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older noncolonized patients with cystic fibrosis. N Engl J Med (1987) 1.59
Response of Pseudomonas cepacia to beta-Lactam antibiotics: utilization of penicillin G as the carbon source. J Bacteriol (1979) 1.58
Pseudomonas cepacia: a new pathogen in patients with cystic fibrosis referred to a large centre in the United Kingdom. Arch Dis Child (1990) 1.55
Mucoid Pseudomonas aeruginosa in cystic fibrosis: signal transduction and histone-like elements in the regulation of bacterial virulence. Mol Microbiol (1991) 1.54
Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis. J Clin Microbiol (1987) 1.49
Diagnosis of chronic Pseudomonas aeruginosa infection in cystic fibrosis by enzyme-linked immunosorbent assay. J Clin Microbiol (1987) 1.49
Progression of cystic fibrosis lung disease as a function of serum immunoglobulin G levels: a 5-year longitudinal study. J Pediatr (1984) 1.48
Role of Pseudomonas aeruginosa exoenzymes in lung infections of patients with cystic fibrosis. Infect Immun (1985) 1.41
A murine model of chronic mucosal colonization by Pseudomonas aeruginosa. Infect Immun (1992) 1.41
Mucinophilic and chemotactic properties of Pseudomonas aeruginosa in relation to pulmonary colonization in cystic fibrosis. Infect Immun (1990) 1.39
Prospective, controlled study of a polyvalent pseudomonas vaccine in cystic fibrosis--three year results. Arch Dis Child (1984) 1.35
Controlled study of Pseudomonas cepacia and Pseudomonas maltophilia in cystic fibrosis. Arch Dis Child (1992) 1.31
IgG antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis. Arch Dis Child (1992) 1.26
Production of lipase by clinical isolates of Pseudomonas cepacia. J Clin Microbiol (1988) 1.25
Immune complexes and humoral response to Pseudomonas aeruginosa in cystic fibrosis. Am Rev Respir Dis (1980) 1.22
Prediction and diagnosis of early Pseudomonas aeruginosa infection in cystic fibrosis: a follow-up study. J Clin Microbiol (1988) 1.20
Development of enzyme linked immunosorbent assay (ELISA) to detect antibodies to Pseudomonas aeruginosa cell surface antigens in sera of patients with cystic fibrosis. J Clin Pathol (1986) 1.19
Longitudinal study of antibody response to lipopolysaccharides during chronic Pseudomonas aeruginosa lung infection in cystic fibrosis. Infect Immun (1988) 1.17
Surface morphology of human airway mucosa: normal, carcinoma or cystic fibrosis. Scanning Microsc (1988) 1.12
Human tracheobronchial mucin: purification and binding to Pseudomonas aeruginosa. Infect Immun (1992) 1.10
Immunology of cystic fibrosis. Br Med Bull (1992) 1.10
Inflammatory markers in cystic fibrosis. Respir Med (1991) 1.07
Rational parameters for antibiotic therapy in patients with cystic fibrosis. Infection (1987) 1.06
Serum IgA antibodies against Pseudomonas aeruginosa in cystic fibrosis. Arch Dis Child (1990) 1.05
Pseudomonas cepacia infection in cystic fibrosis. Lancet (1992) 1.04
Safety and immunogenicity of Pseudomonas aeruginosa conjugate A vaccine in cystic fibrosis. Lancet (1991) 1.02
Pathogenic factors of Pseudomonas cepacia isolates from patients with cystic fibrosis. J Med Microbiol (1990) 1.00
Use of immunoblot detection of serum antibodies in the diagnosis of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis. J Med Microbiol (1988) 0.99
Differential adhesion of Pseudomonas aeruginosa to human respiratory epithelial cells in primary culture. J Clin Invest (1991) 0.98
Longitudinal serum IgG response to Pseudomonas cepacia surface antigens in cystic fibrosis. Pediatr Pulmonol (1991) 0.97
Pseudomonas aeruginosa flagellar antibodies in patients with cystic fibrosis. J Clin Microbiol (1989) 0.97
Effects of subminimal inhibitory concentrations of antibiotics on the adherence of Pseudomonas aeruginosa to tracheobronchial mucin. J Antimicrob Chemother (1987) 0.92
IgA and IgG antibodies against surface antigens of Pseudomonas aeruginosa in sputum and serum from patients with cystic fibrosis. Acta Pathol Microbiol Scand C (1979) 0.91
Serum IgG antibody to outer membrane antigens of Pseudomonas cepacia and Pseudomonas aeruginosa in cystic fibrosis. J Infect Dis (1988) 0.89
Antibody response to Pseudomonas aeruginosa antigens in cystic fibrosis. Antibiot Chemother (1971) (1989) 0.89
Comparative analysis of serum antibody responses to Pseudomonas aeruginosa exotoxin A by cystic fibrosis and intensive care unit patients. J Clin Microbiol (1983) 0.86
The role of bacterial adhesion in cystic fibrosis including the staphylococcal aspect. Infection (1990) 0.86
The effect of sublethal levels of antibiotics on the pathogenicity of Pseudomonas aeruginosa for tracheal tissue. J Antimicrob Chemother (1987) 0.85
Temocillin and cystic fibrosis: outcome of intravenous administration in patients infected with Pseudomonas cepacia. J Antimicrob Chemother (1992) 0.83
Lung transplantation for cystic fibrosis. Br Med Bull (1992) 0.81
The importance of extracellular antigens in Pseudomonas cepacia infections. J Med Microbiol (1988) 0.81
Iron-regulated outer membrane proteins and virulence in Pseudomonas aeruginosa. Antibiot Chemother (1971) (1989) 0.81
Prognostic implications of circulating immune complexes and Pseudomonas aeruginosa-specific antibodies in cystic fibrosis. J Clin Lab Immunol (1987) 0.80
Significance of immunologic factors in cystic fibrosis. Scand J Gastroenterol Suppl (1988) 0.77
Serum C-reactive protein in assessment of pulmonary exacerbations and antimicrobial therapy in cystic fibrosis. J Pediatr (1988) 0.76
Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet (1993) 7.12
DNA and RNA oligomer thermodynamics: the effect of mismatched bases on double-helix stability. Biopolymers (1981) 2.62
Pseudomonas cepacia in inpatients with cystic fibrosis. Lancet (1991) 2.27
Microbiology of lung infection in cystic fibrosis. Br Med Bull (1992) 2.22
Do all Pseudomonas cepacia produce carbapenemases? J Antimicrob Chemother (1993) 2.00
Burkholderia cepacia and cystic fibrosis: do natural environments present a potential hazard? J Clin Microbiol (1995) 1.79
Multi-resistance isolates possessing characteristics of both Burkholderia (Pseudomonas) cepacia and Burkholderia gladioli from patients with cystic fibrosis. J Antimicrob Chemother (1994) 1.68
Electrophoretic concentration of macromolecules. Anal Biochem (1978) 1.56
Association of endocrine disruptors and obesity: perspectives from epidemiological studies. Int J Androl (2010) 1.36
Comparison of the kinetics of ribooligonucleotide, deoxyribooligonucleotide, and hybrid oligonucleotide double-strand formation by temperature-jump kinetics. Biochemistry (1982) 1.29
Reversed-phase high-performance liquid chromatographic assay for the adenovirus type 5 proteome. J Chromatogr B Biomed Sci Appl (1999) 1.14
A novel bioassay for the determination of neutralizing antibodies to IFN-beta1b. J Interferon Cytokine Res (1998) 1.04
Copper metabolism in American retinitis pigmentosa patients. Br J Ophthalmol (1978) 1.01
Yaws in Ghana. Rev Infect Dis (1985) 0.98
Pseudomembranous colitis complicated by bacteremia due to Streptococcus faecalis. J Infect Dis (1983) 0.96
Intercalation of ethidium ion into DNA and RNA oligonucleotides. Biopolymers (1984) 0.96
Stabilities of disulfide bond intermediates in the folding of apamin. Biochemistry (1992) 0.95
Preferential DNA repair of alkali-labile sites within the active insulin gene. J Biol Chem (1990) 0.94
Simplified micro-scale procedure for preparing samples for theophylline determination by liquid chromatography. Clin Chem (1977) 0.94
Three per second spike-wave in digitalis toxicity. Report of a case. Arch Neurol (1971) 0.93
Direct measurement of the equilibrium between glutathione and dithiothreitol by high performance liquid chromatography. FEBS Lett (1991) 0.93
Electromyographic examination of the erectores spinae in patients suspected of having nerve root lesions. Electroencephalogr Clin Neurophysiol (1967) 0.91
The isolation of an additional prostaglandin derivative from the enzymatic cyclization of homo-gamma-linolenic acid. Biochem Biophys Res Commun (1965) 0.91
Mechanism of the sex difference in neuronal ischemic cell death. Neuroscience (2012) 0.91
Manufacture of antithymocyte globulin (ATGAM) for clinical trials. Transplantation (1979) 0.90
Janus kinases and their role in growth and disease. Life Sci (1999) 0.89
Ethidium ion binds more strongly to a DNA double helix with a bulged cytosine than to a regular double helix. Biochemistry (1985) 0.88
Serum sensitivity of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis. FEMS Immunol Med Microbiol (1994) 0.88
Solution structure of tertiapin determined using nuclear magnetic resonance and distance geometry. Proteins (1993) 0.87
Resurgence of yaws in Ghana. Lancet (1983) 0.86
Expression of resolvin D1 biosynthetic pathways in salivary epithelium. J Dent Res (2014) 0.86
Dissecting subintimal hematomas of the intracranial arteries: report of a case. J Am Osteopath Assoc (1968) 0.85
The novel protein kinase of the RR1 subunit of herpes simplex virus has autophosphorylation and transphosphorylation activity that differs in its ATP requirements for HSV-1 and HSV-2. Virology (1996) 0.84
Cooperative disulfide bond formation in apamin. Biochemistry (1992) 0.84
Blood nitrite and nitrate concentration after oral and intravenous administration of glyceryl trinitrate in rabbits. J Pharm Sci (1966) 0.82
Helix formation in model peptides based on nucleolin TPAKK motifs. Biopolymers (1995) 0.81
A complete nucleolin cDNA sequence from Xenopus laevis. Nucleic Acids Res (1993) 0.81
One-disulfide intermediates of apamin exhibit native-like structure. Biochemistry (1994) 0.80
New technologies for use in the surveillance and control of yaws. Rev Infect Dis (1985) 0.79
Methylation and restriction endonuclease cleavage of linear Z-DNA in the presence of hexamminecobalt (III) ions. Nucleic Acids Res (1986) 0.79
Extensive modifications for methionine enhancement in the beta-barrels do not alter the structural stability of the bean seed storage protein phaseolin. J Protein Chem (1995) 0.78
Impact of the control of endemic treponemal diseases in Ghana on other diseases. Rev Infect Dis (1985) 0.78
Strategies for selecting mutation sites for methionine enhancement in the bean seed storage protein phaseolin. J Protein Chem (1993) 0.78
Site-directed mutagenesis of rabbit muscle phosphofructokinase cDNA. Mutations at glutamine 200 affect the allosteric properties of the enzyme. J Biol Chem (1993) 0.77
Densitometry: modern approaches advance an established technique. Biotechniques (1994) 0.76
Arthroplasty of the hip for idiopathic degenerative joint disease. Surg Gynecol Obstet (1967) 0.75
Acute cerebral vascular insufficiency in young patients. Acta Neurol Scand (1967) 0.75
Electromyographic examination of the erector spinae muscle in patients suspected of having nerve root lesions. J Am Osteopath Assoc (1967) 0.75
A study to determine the accuracy of a computerized algorithm for interpretation of EEGs. J Okla State Med Assoc (2001) 0.75
Clear cell myeloma. Am J Surg Pathol (1985) 0.75
Testicular seminoma as a cause of paraplegia: a case report. J Urol (1966) 0.75
Familial motor neuron disease, non-Chamorro type: report of kinship. Acta Neurol Scand (1971) 0.75
Effects of glyceryl trinitrate on the aortic strip of rabbits. J Pharm Pharmacol (1967) 0.75
Problems in everyday practice. J Am Pharm Assoc (1966) 0.75
Effect of glyceryl trinitrate on extracellular fluid space of aortic strips. J Pharm Sci (1966) 0.75
Cryptococcic meningo-encephalitis. J Tenn Med Assoc (1967) 0.75
Simplified automated method for determination of urinary or serum uric acid, based on reduction of ferric-phenanthroline complex. Clin Chem (1975) 0.75
Broiler pigmentation potency of neoxanthin and violaxanthin relative to lutein. Poult Sci (1969) 0.75
Optimum conditions for high-resolution gradient analysis. Anal Biochem (1976) 0.75
Biophysical analysis of phaseolin denaturation induced by urea, guanidinium chloride, pH, and temperature. J Protein Chem (1992) 0.75
Distribution of charged residues stabilizes individual helices in myoglobins. J Biomol Struct Dyn (1990) 0.75
Studies on the rosette inhibition assay. Improvement of the method and correlation with monkey skin graft prolongation. Transplantation (1975) 0.75
Proton-induced x-ray emission analysis of single human hair roots. Science (1977) 0.75
Traumatic rupture of the diaphragm: a method of diagnosis. J Can Assoc Radiol (1980) 0.75
Role of glycine 212 in the allosteric behavior of phosphofructokinase from Bacillus stearothermophilus. Biochemistry (1995) 0.75
Stabilization of xanthophyll and carotene by ethoxyquin during thin-layer chromatography. J Chromatogr (1967) 0.75